Latest Breaking News On - Lepu biopharma co ltd - Page 1 : comparemela.com

HONG KONG, Feb. 22, 2023 /PRNewswire/ Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture.

Lepu biopharmaKeymed biosciencesBo chenBiosciences incKeymed biosciences incLepu biopharma co ltdStock codeChief executive officerBoard chairmanSenior vice presidentBiologics engineeringOncology targeted delivery